annual EBITDA:
$138.29M+$28.64M(+26.12%)Summary
- As of today (May 21, 2025), CORT annual EBITDA is $138.29 million, with the most recent change of +$28.64 million (+26.12%) on December 31, 2024.
- During the last 3 years, CORT annual EBITDA has risen by +$10.33 million (+8.08%).
- CORT annual EBITDA is now at all-time high.
Performance
CORT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$3.88M-$21.84M(-84.92%)Summary
- As of today (May 21, 2025), CORT quarterly EBITDA is $3.88 million, with the most recent change of -$21.84 million (-84.92%) on March 31, 2025.
- Over the past year, CORT quarterly EBITDA has dropped by -$25.80 million (-86.93%).
- CORT quarterly EBITDA is now -91.77% below its all-time high of $47.10 million, reached on September 30, 2024.
Performance
CORT quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$112.49M-$25.80M(-18.66%)Summary
- As of today (May 21, 2025), CORT TTM EBITDA is $112.49 million, with the most recent change of -$25.80 million (-18.66%) on March 31, 2025.
- Over the past year, CORT TTM EBITDA has dropped by -$11.12 million (-9.00%).
- CORT TTM EBITDA is now -22.16% below its all-time high of $144.51 million, reached on September 30, 2024.
Performance
CORT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CORT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +26.1% | -86.9% | -9.0% |
| 3 y3 years | +8.1% | -85.9% | -16.8% |
| 5 y5 years | +21.5% | -89.9% | -15.2% |
CORT EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +26.1% | -91.8% | at low | -22.2% | +10.9% |
| 5 y | 5-year | at high | +26.1% | -91.8% | at low | -22.2% | +10.9% |
| alltime | all time | at high | +433.9% | -91.8% | +130.2% | -22.2% | +359.6% |
CORT EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $3.88M(-84.9%) | $112.49M(-18.7%) |
| Dec 2024 | $138.29M(+26.1%) | $25.72M(-45.4%) | $138.29M(-4.3%) |
| Sep 2024 | - | $47.10M(+31.6%) | $144.51M(+12.1%) |
| Jun 2024 | - | $35.79M(+20.6%) | $128.88M(+4.3%) |
| Mar 2024 | - | $29.68M(-7.1%) | $123.61M(+12.7%) |
| Dec 2023 | $109.64M(-5.5%) | $31.94M(+1.5%) | $109.64M(+8.1%) |
| Sep 2023 | - | $31.47M(+3.1%) | $101.43M(-1.2%) |
| Jun 2023 | - | $30.52M(+94.3%) | $102.65M(-1.5%) |
| Mar 2023 | - | $15.71M(-33.8%) | $104.22M(-10.2%) |
| Dec 2022 | $116.08M(-9.3%) | $23.72M(-27.4%) | $116.08M(-10.9%) |
| Sep 2022 | - | $32.69M(+1.8%) | $130.23M(-3.2%) |
| Jun 2022 | - | $32.10M(+16.4%) | $134.54M(-0.4%) |
| Mar 2022 | - | $27.57M(-27.2%) | $135.14M(+5.6%) |
| Dec 2021 | $127.95M(-1.9%) | $37.87M(+2.3%) | $127.95M(+5.6%) |
| Sep 2021 | - | $37.00M(+13.2%) | $121.16M(+10.7%) |
| Jun 2021 | - | $32.70M(+60.4%) | $109.44M(-2.7%) |
| Mar 2021 | - | $20.38M(-34.4%) | $112.51M(-13.7%) |
| Dec 2020 | $130.44M(+14.6%) | $31.07M(+22.9%) | $130.44M(-3.3%) |
| Sep 2020 | - | $25.28M(-29.3%) | $134.94M(-5.8%) |
| Jun 2020 | - | $35.77M(-6.6%) | $143.24M(+8.0%) |
| Mar 2020 | - | $38.31M(+7.7%) | $132.63M(+16.6%) |
| Dec 2019 | $113.78M(+26.8%) | $35.58M(+6.0%) | $113.78M(+10.3%) |
| Sep 2019 | - | $33.58M(+33.5%) | $103.17M(+11.4%) |
| Jun 2019 | - | $25.16M(+29.3%) | $92.62M(+5.1%) |
| Mar 2019 | - | $19.46M(-22.0%) | $88.15M(-1.8%) |
| Dec 2018 | $89.73M(+69.4%) | $24.97M(+8.4%) | $89.73M(+3.7%) |
| Sep 2018 | - | $23.03M(+11.3%) | $86.51M(+12.1%) |
| Jun 2018 | - | $20.69M(-1.7%) | $77.14M(+11.4%) |
| Mar 2018 | - | $21.04M(-3.2%) | $69.25M(+30.8%) |
| Dec 2017 | $52.96M(+415.9%) | $21.75M(+59.2%) | $52.96M(+46.1%) |
| Sep 2017 | - | $13.66M(+6.7%) | $36.24M(+41.2%) |
| Jun 2017 | - | $12.80M(+169.4%) | $25.67M(+78.3%) |
| Mar 2017 | - | $4.75M(-5.4%) | $14.40M(+40.3%) |
| Dec 2016 | $10.27M(-412.2%) | $5.02M(+62.4%) | $10.27M(+48.3%) |
| Sep 2016 | - | $3.09M(+101.9%) | $6.92M(+74.7%) |
| Jun 2016 | - | $1.53M(+147.5%) | $3.96M(+199.9%) |
| Mar 2016 | - | $619.00K(-63.1%) | $1.32M(-140.2%) |
| Dec 2015 | -$3.29M(-88.0%) | $1.68M(+1172.0%) | -$3.29M(-58.9%) |
| Sep 2015 | - | $132.00K(-111.9%) | -$8.01M(-39.4%) |
| Jun 2015 | - | -$1.11M(-72.2%) | -$13.20M(-29.2%) |
| Mar 2015 | - | -$3.99M(+31.3%) | -$18.64M(-32.2%) |
| Dec 2014 | -$27.48M(-33.7%) | -$3.04M(-40.0%) | -$27.48M(-20.2%) |
| Sep 2014 | - | -$5.06M(-22.6%) | -$34.45M(-11.9%) |
| Jun 2014 | - | -$6.54M(-49.0%) | -$39.10M(-9.7%) |
| Mar 2014 | - | -$12.83M(+28.2%) | -$43.32M(+4.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | -$41.42M(+14.3%) | -$10.01M(+3.0%) | -$41.42M(+0.1%) |
| Sep 2013 | - | -$9.72M(-9.7%) | -$41.38M(+5.2%) |
| Jun 2013 | - | -$10.76M(-1.5%) | -$39.33M(+8.8%) |
| Mar 2013 | - | -$10.93M(+9.7%) | -$36.15M(-0.3%) |
| Dec 2012 | -$36.24M(+12.1%) | -$9.97M(+30.0%) | -$36.24M(+0.1%) |
| Sep 2012 | - | -$7.67M(+1.0%) | -$36.20M(+3.5%) |
| Jun 2012 | - | -$7.59M(-31.2%) | -$34.97M(-3.5%) |
| Mar 2012 | - | -$11.03M(+11.1%) | -$36.26M(+12.2%) |
| Dec 2011 | -$32.33M(+24.6%) | -$9.92M(+54.2%) | -$32.33M(+12.5%) |
| Sep 2011 | - | -$6.44M(-27.4%) | -$28.73M(-2.3%) |
| Jun 2011 | - | -$8.87M(+25.0%) | -$29.40M(+9.0%) |
| Mar 2011 | - | -$7.10M(+12.2%) | -$26.97M(+4.0%) |
| Dec 2010 | -$25.93M(+28.1%) | -$6.33M(-10.9%) | -$25.94M(+4.7%) |
| Sep 2010 | - | -$7.10M(+10.3%) | -$24.77M(+10.9%) |
| Jun 2010 | - | -$6.44M(+6.3%) | -$22.33M(+7.5%) |
| Mar 2010 | - | -$6.06M(+17.4%) | -$20.77M(+2.6%) |
| Dec 2009 | -$20.24M(+2.9%) | -$5.16M(+10.6%) | -$20.24M(-4.0%) |
| Sep 2009 | - | -$4.67M(-4.4%) | -$21.09M(-1.1%) |
| Jun 2009 | - | -$4.88M(-11.8%) | -$21.32M(+0.9%) |
| Mar 2009 | - | -$5.53M(-8.0%) | -$21.13M(+7.4%) |
| Dec 2008 | -$19.68M(+60.9%) | -$6.01M(+22.8%) | -$19.68M(+8.8%) |
| Sep 2008 | - | -$4.90M(+4.6%) | -$18.08M(+7.7%) |
| Jun 2008 | - | -$4.68M(+14.8%) | -$16.79M(+22.7%) |
| Mar 2008 | - | -$4.08M(-7.6%) | -$13.69M(+11.9%) |
| Dec 2007 | -$12.23M(-52.2%) | -$4.42M(+22.2%) | -$12.23M(+3.6%) |
| Sep 2007 | - | -$3.61M(+129.3%) | -$11.80M(-19.9%) |
| Jun 2007 | - | -$1.58M(-40.0%) | -$14.73M(-30.6%) |
| Mar 2007 | - | -$2.63M(-34.2%) | -$21.22M(-17.0%) |
| Dec 2006 | -$25.57M(+25.0%) | -$3.99M(-39.1%) | -$25.57M(-3.1%) |
| Sep 2006 | - | -$6.55M(-18.8%) | -$26.39M(+4.2%) |
| Jun 2006 | - | -$8.06M(+15.5%) | -$25.32M(+17.0%) |
| Mar 2006 | - | -$6.98M(+45.2%) | -$21.65M(+7.4%) |
| Dec 2005 | -$20.45M(+41.7%) | -$4.80M(-12.3%) | -$20.15M(-1.8%) |
| Sep 2005 | - | -$5.48M(+25.0%) | -$20.51M(+7.4%) |
| Jun 2005 | - | -$4.39M(-20.0%) | -$19.09M(+6.9%) |
| Mar 2005 | - | -$5.48M(+6.1%) | -$17.86M(+23.7%) |
| Dec 2004 | -$14.44M(+45.1%) | -$5.17M(+27.2%) | -$14.44M(+27.9%) |
| Sep 2004 | - | -$4.06M(+28.7%) | -$11.28M(+20.3%) |
| Jun 2004 | - | -$3.15M(+53.5%) | -$9.38M(+2.6%) |
| Mar 2004 | - | -$2.06M(+2.0%) | -$9.14M(-8.1%) |
| Dec 2003 | -$9.95M(-47.1%) | -$2.01M(-6.6%) | -$9.95M(+25.4%) |
| Sep 2003 | - | -$2.16M(-26.1%) | -$7.93M(+37.3%) |
| Jun 2003 | - | -$2.92M(+2.0%) | -$5.78M(+102.0%) |
| Mar 2003 | - | -$2.86M | -$2.86M |
| Dec 2002 | -$18.80M(+134.8%) | - | - |
| Dec 2001 | -$8.01M | - | - |
FAQ
- What is Corcept Therapeutics Incorporated annual EBITDA?
- What is the all time high annual EBITDA for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated annual EBITDA year-on-year change?
- What is Corcept Therapeutics Incorporated quarterly EBITDA?
- What is the all time high quarterly EBITDA for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly EBITDA year-on-year change?
- What is Corcept Therapeutics Incorporated TTM EBITDA?
- What is the all time high TTM EBITDA for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated TTM EBITDA year-on-year change?
What is Corcept Therapeutics Incorporated annual EBITDA?
The current annual EBITDA of CORT is $138.29M
What is the all time high annual EBITDA for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual EBITDA is $138.29M
What is Corcept Therapeutics Incorporated annual EBITDA year-on-year change?
Over the past year, CORT annual EBITDA has changed by +$28.64M (+26.12%)
What is Corcept Therapeutics Incorporated quarterly EBITDA?
The current quarterly EBITDA of CORT is $3.88M
What is the all time high quarterly EBITDA for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly EBITDA is $47.10M
What is Corcept Therapeutics Incorporated quarterly EBITDA year-on-year change?
Over the past year, CORT quarterly EBITDA has changed by -$25.80M (-86.93%)
What is Corcept Therapeutics Incorporated TTM EBITDA?
The current TTM EBITDA of CORT is $112.49M
What is the all time high TTM EBITDA for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high TTM EBITDA is $144.51M
What is Corcept Therapeutics Incorporated TTM EBITDA year-on-year change?
Over the past year, CORT TTM EBITDA has changed by -$11.12M (-9.00%)